REG - Eco Animal Health Gp - Renewal of revolving credit facility

ECO Animal HealthAnnouncement

Thu 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260604:nRSD8968Ga&default-theme=true

RNS Number : 8968G  Eco Animal Health Group PLC  04 June 2026

4 June 2026

 

ECO Animal Health Group plc

("ECO" or the "Company")

 

Renewal of revolving credit facility

 

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health
company with a portfolio of marketed veterinary products and a maturing
proprietary R&D pipeline, announces that it has renewed its committed
revolving credit facility ("RCF") agreement with its bank, National
Westminster Bank plc ("NatWest") on more favourable terms than previously
existed.

 

The renewed facility provides for drawings of up to £10 million in flexible
amounts and replaces the existing £10 million RCF which was due to expire on
30 June 2026. The Company has also renewed its existing £5m overdraft
facility, maintaining total banking facilities of £15 million, with the new
RCF and overdraft facility terms expiring on 30 June 2031.

 

The Company has not previously utilised the RCF and there are no immediate
plans to make drawings under the facility; it exists to provide immediate
liquidity for business expansion initiatives.

 

Following the positive trading update announced in March, ECO is currently
preparing its audited results for the year ended 31 March 2026 and anticipates
releasing these around the middle of July 2026.

 

-Ends-

Contacts

                                                                020 8447 8899

 ECO Animal Health Group plc

 David Hallas (Chief Executive Officer)

 Christopher Wilks (Chief Financial Officer)

 ICR Healthcare (Financial PR)                                  020 3709 5700

 Mary-Jane Elliott

 Jessica Hodgson

 Singer Capital Markets (Nominated Adviser & Joint Broker)      020 7496 3000

 Philip Davies

 Jennifer Boorer

 Jalini Kalaravy

 Samed Ethemi

 Panmure Liberum (Joint Broker)                                 020 3100 2000

 Emma Earl

 Will Goode

 Mark Rogers

 Rupert Dearden

 Equity Development                                             020 7065 2692

 Hannah Crowe

 Matt Evans

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing
branded veterinary pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary R&D
pipeline.

Headquartered in the UK, with global offices including R&D and
manufacturing, we have marketing authorisations in over 70 countries and
employ over 200 people worldwide.

Our lead product, Aivlosin(®) is a proprietary, patented medication which is
effective against both respiratory and intestinal diseases in pigs and
poultry.

Click here for more information: https://ecoanimalhealth.com
(https://ecoanimalhealth.com)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBSGDLRXGDGLX



            Copyright 2019 Regulatory News Service, all rights reserved